Equities

abrdn World Healthcare Fund

THW:NYQ

abrdn World Healthcare Fund

Actions
FinancialsClosed End Investments
  • Price (USD)11.82
  • Today's Change-0.13 / -1.09%
  • Shares traded170.34k
  • 1 Year change+5.35%
  • Beta0.8859
Data delayed at least 15 minutes, as of Nov 23 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year abrdn World Healthcare Fund grew revenues 5.47% from 12.11m to 12.78m while net income improved from a loss of 62.84m to a gain of 37.62m.
Gross margin-13.78%
Net profit margin389.18%
Operating margin-19.44%
Return on assets8.10%
Return on equity10.21%
Return on investment8.16%
More ▼

Cash flow in USDView more

In 2023, abrdn World Healthcare Fund increased its cash reserves by 116.16%, or 1.15k. The company earned 44.84m from its operations for a Cash Flow Margin of 351.00%. In addition the company used on investing activities and also paid 44.84m in financing cash flows.
Cash flow per share--
Price/Cash flow per share--
Book value per share12.53
Tangible book value per share12.53
More ▼

Balance sheet in USDView more

abrdn World Healthcare Fund has a Debt to Total Capital ratio of 20.03%, a lower figure than the previous year's 25.02%.
Current ratio--
Quick ratio--
Total debt/total equity0.2505
Total debt/total capital0.2003
More ▼

Growth rates in USD

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 6.57% and 158.94%, respectively. The positive trend in dividend payments is noteworthy since only some companies in the Investment Services industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)9.96%
Div growth rate (5 year)-0.46%
Payout ratio (TTM)108.92%
EPS growth(5 years)-1.46
EPS (TTM) vs
TTM 1 year ago
271.25
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.